Early Response to Eptinezumab Indicates High Likelihood of Continued Response in Patients with Chronic Migraine
The Journal of Headache and Pain（2022）
Key words
Eptinezumab,Chronic migraine,Migraine prevention,Clinical response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined